"Cholinergic Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Any drug used for its actions on cholinergic systems. Included here are agonists and antagonists, drugs that affect the life cycle of ACETYLCHOLINE, and drugs that affect the survival of cholinergic neurons. The term cholinergic agents is sometimes still used in the narrower sense of MUSCARINIC AGONISTS, although most modern texts discourage that usage.
| Descriptor ID |
D018678
|
| MeSH Number(s) |
D27.505.519.625.120 D27.505.696.577.120
|
| Concept/Terms |
Cholinergic Agents- Cholinergic Agents
- Agents, Cholinergic
- Cholinergics
- Acetylcholine Agents
- Agents, Acetylcholine
- Cholinergic Drugs
- Drugs, Cholinergic
Nicotinic Effect- Nicotinic Effect
- Effect, Nicotinic
- Nicotinic Effects
- Effects, Nicotinic
Cholinergic Effect- Cholinergic Effect
- Effect, Cholinergic
- Cholinergic Effects
- Effects, Cholinergic
Muscarinic Effect- Muscarinic Effect
- Effect, Muscarinic
- Muscarinic Effects
- Effects, Muscarinic
|
Below are MeSH descriptors whose meaning is more general than "Cholinergic Agents".
Below are MeSH descriptors whose meaning is more specific than "Cholinergic Agents".
This graph shows the total number of publications written about "Cholinergic Agents" by people in this website by year, and whether "Cholinergic Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 1 | 1 |
| 2001 | 0 | 1 | 1 |
| 2010 | 1 | 0 | 1 |
| 2019 | 1 | 0 | 1 |
| 2021 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cholinergic Agents" by people in Profiles.
-
Falangola MF, Nie X, Ward R, Dhiman S, Voltin J, Nietert PJ, Jensen JH. Diffusion MRI detects basal forebrain cholinergic abnormalities in the 3xTg-AD mouse model of Alzheimer's disease. Magn Reson Imaging. 2021 11; 83:1-13.
-
Leyrer-Jackson JM, Holter M, Overby PF, Newbern JM, Scofield MD, Olive MF, Gipson CD. Accumbens Cholinergic Interneurons Mediate Cue-Induced Nicotine Seeking and Associated Glutamatergic Plasticity. eNeuro. 2021 Jan-Feb; 8(1).
-
Rajaee S, Holder T, Indes JE, Muhs B, Sarac T, Sumpio B, Toll BA, Ochoa Chaar CI. A Pilot Study of a Standardized Smoking Cessation Intervention for Patients with Vascular Disease. Ann Vasc Surg. 2019 Nov; 61:91-99.e3.
-
Liao VH, Liu JT, Li WH, Yu CW, Hsieh YC. Caenorhabditis elegans bicarbonate transporter ABTS-1 is involved in arsenite toxicity and cholinergic signaling. Chem Res Toxicol. 2010 May 17; 23(5):926-32.
-
Gerashchenko D, Salin-Pascual R, Shiromani PJ. Effects of hypocretin-saporin injections into the medial septum on sleep and hippocampal theta. Brain Res. 2001 Sep 14; 913(1):106-15.
-
Shiromani PJ, Schwartz WJ. Towards a molecular biology of the circadian clock and sleep of mammals. Adv Neuroimmunol. 1995; 5(2):217-30.